| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-29 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0068 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate |
1991-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c71338e528be17dd2fe9c1730d8972e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5b18c8b267e325e796a83f5dddc8e0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_859d3973375ddef8fcbc1447e69113f2 |
| publicationDate |
1992-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9209200-A1 |
| titleOfInvention |
Novel polypeptides for promoting cell attachment |
| abstract |
Novel polypeptides derived from human fibronectin are described which bind to integrin receptors expressed by cells. The receptor binding site of human fibronectin begins at amino acid residue (1394) and ends at residue (1400) of fibronectin. The polypeptides facilitate attachment of cells to substrates either alone or in conjunction with RGD-containing peptides. Vectors, fusion proteins and antibodies are also described. Methods for promoting cell attachment and for inhibiting cell adhesion are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0673384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5843182-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120064050-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0928340-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2463301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101976207-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9193779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8921516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5899936-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0673384-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0928340-A4 |
| priorityDate |
1990-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |